BELLICUM PHARMACEUTICALS, INC (39) | Uncategorized (3)
- Cancer Research Grant Contract, dated July 27, 2011, by and between the Registrant and the Cancer Prevention and Research Institute of Texas (Filed With SEC on November 5, 2020)
- Omnibus Amendment Agreement, dated October 3, 2014, by and between Registrant and ARIAD Pharmaceuticals, Inc (Filed With SEC on November 5, 2020)
- Description of Securities (Filed With SEC on March 12, 2020)
